Literature DB >> 30108837

Synthesis of thioether andrographolide derivatives and their inhibitory effect against cancer cells.

Yi Liu1, Ren-Ming Liang1, Qing-Ping Ma1, Kai Xu1, Xin-Yong Liang1, Wei Huang2,3, Robert Sutton3, Jie Ding1, Paul M O'Neil3, Chun-Ru Cheng1,3,4.   

Abstract

A series of novel thioether andrographolide derivatives were synthesized by incorporating various aromatic (or heteroaromatic) substituents into C-12 or 14-OH. A total of 38 andrographolide derivatives were prepared and evaluated for their in vitro inhibitory activity against cancer cells. All the derivatives exhibited better activity against prostate cancer cells (PC-3) than the parent compound. Among these, compounds 6a, 8, 9, 17, 19, 31, and 32 demonstrated good activity. These compounds were further evaluated for their anticancer activities against other cancer cell lines including MCF-7, MDA-MB-231, and A549. Compounds 31 and 32 showed excellent activity against MCF-7 with an IC50 value of 0.7 and 0.6 μM, respectively. The absolute configuration of 15a was determined via single-crystal X-ray diffraction. The activity of 6a (12S), which was the precursor of 15a, was better than that of the diastereoisomer 6b (12R). Moreover, the preliminary structure-activity relationship has been summarized. The results obtained herein are very important for further optimization of andrographolide.

Entities:  

Year:  2017        PMID: 30108837      PMCID: PMC6071759          DOI: 10.1039/c7md00169j

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  17 in total

Review 1.  Biological activities and corresponding SARs of andrographolide and its derivatives.

Authors:  Bin Zhou; Dayong Zhang; Xiaoming Wu
Journal:  Mini Rev Med Chem       Date:  2013-02       Impact factor: 3.862

2.  Bioavailability of andrographolide and protection against carbon tetrachloride-induced oxidative damage in rats.

Authors:  Haw-Wen Chen; Chin-Shiu Huang; Chien-Chun Li; Ai-Hsuan Lin; Yu-Ju Huang; Tsu-Shing Wang; Hsien-Tsung Yao; Chong-Kuei Lii
Journal:  Toxicol Appl Pharmacol       Date:  2014-08-07       Impact factor: 4.219

Review 3.  Andrographolide: progression in its modifications and applications - a patent review (2012 - 2014).

Authors:  Chantana Aromdee
Journal:  Expert Opin Ther Pat       Date:  2014-10       Impact factor: 6.674

4.  New substituted C-19-andrographolide analogues with potent cytotoxic activities.

Authors:  Uthaiwan Sirion; Sakkasem Kasemsook; Kanoknetr Suksen; Pawinee Piyachaturawat; Apichart Suksamrarn; Rungnapha Saeeng
Journal:  Bioorg Med Chem Lett       Date:  2011-11-28       Impact factor: 2.823

5.  Synthesis and anticancer activity of some novel indolo[3,2-b]andrographolide derivatives as apoptosis-inducing agents.

Authors:  Yaping Song; Zhengyuan Xin; Yumeng Wan; Jiabin Li; Boping Ye; Xiaowen Xue
Journal:  Eur J Med Chem       Date:  2014-12-11       Impact factor: 6.514

6.  Synthesis and structure-activity relationships of andrographolide analogues as novel cytotoxic agents.

Authors:  Srinivas Nanduri; Vijay Kumar Nyavanandi; Siva Sanjeeva Rao Thunuguntla; Sridevi Kasu; Mahesh Kumar Pallerla; P Sai Ram; Sriram Rajagopal; R Ajaya Kumar; Rajagopalan Ramanujam; J Moses Babu; Krishnamurthi Vyas; A Sivalakshmi Devi; G Om Reddy; Venkateswarlu Akella
Journal:  Bioorg Med Chem Lett       Date:  2004-09-20       Impact factor: 2.823

7.  Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore.

Authors:  Wei Chen; Lina Feng; Hao Nie; Xiaodong Zheng
Journal:  Carcinogenesis       Date:  2012-08-06       Impact factor: 4.944

8.  Synthesis and preliminary biologic activity evaluation of nitric oxide-releasing andrographolide derivatives in RIN-m cells.

Authors:  Zhibin Liang; Enming Du; Lipeng Xu; Yewei Sun; Gaoxiao Zhang; Pei Yu; Yuqiang Wang
Journal:  Chem Pharm Bull (Tokyo)       Date:  2014       Impact factor: 1.645

9.  Synthesis and evaluation of antibacterial activities of andrographolide analogues.

Authors:  Xiaojian Jiang; Pei Yu; Jie Jiang; Zaijun Zhang; Zhongli Wang; Zhaoqi Yang; Zhiming Tian; Susan C Wright; James W Larrick; Yuqiang Wang
Journal:  Eur J Med Chem       Date:  2008-12-25       Impact factor: 6.514

10.  Synthesis and biological evaluation of andrographolide analogues as anti-cancer agents.

Authors:  Ranjan Preet; Biswajit Chakraborty; Sumit Siddharth; Purusottam Mohapatra; Dipon Das; Shakti Ranjan Satapathy; Supriya Das; Nakul C Maiti; Prakas R Maulik; Chanakya Nath Kundu; Chinmay Chowdhury
Journal:  Eur J Med Chem       Date:  2014-07-24       Impact factor: 6.514

View more
  3 in total

1.  Identification of potential andrographolide-based drug candidate against Keap1-Nrf2 pathway through rigorous cheminformatics screening.

Authors:  Priyanka Jain; C Sudandira Doss
Journal:  Mol Divers       Date:  2022-04-25       Impact factor: 2.943

2.  Andrographolide attenuates viral myocarditis through interactions with the IL-10/STAT3 and P13K/AKT/NF-κβ signaling pathways.

Authors:  Yaxin Zhao; Meng Wang; Yang Li; Wanting Dong
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

3.  Synthesis, Characterization and Bioactivity Evaluation of a Novel Nano Bagasse Xylan/Andrographolide Grafted and Esterified Derivative.

Authors:  Kexin Tian; Heping Li; Bin Zhao; Yue Su; Zhiming Zou; Wenli Wang
Journal:  Polymers (Basel)       Date:  2022-08-22       Impact factor: 4.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.